I do agree shail that APDN does not want to become a one trick pony. Hopefully the DLA mandate is a fantastic endorsement of our products and we will find greater success elsewhere. I do think the pharm market could be very special. Especially given the health risks of counterfeits.
Thanks for your comments I hope you get some answers to your questions tomorrow :)